Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design.
Repository Usage Stats
BACKGROUND: Type 2 diabetes is a prevalent chronic condition globally that results in extensive morbidity, decreased quality of life, and increased health services utilization. Lifestyle changes can prevent the development of diabetes, but require patient engagement. Genetic risk testing might represent a new tool to increase patients' motivation for lifestyle changes. Here we describe the rationale, development, and design of a randomized controlled trial (RCT) assessing the clinical and personal utility of incorporating type 2 diabetes genetic risk testing into comprehensive diabetes risk assessments performed in a primary care setting. METHODS/DESIGN: Patients are recruited in the laboratory waiting areas of two primary care clinics and enrolled into one of three study arms. Those interested in genetic risk testing are randomized to receive either a standard risk assessment (SRA) for type 2 diabetes incorporating conventional risk factors plus upfront disclosure of the results of genetic risk testing ("SRA+G" arm), or the SRA alone ("SRA" arm). Participants not interested in genetic risk testing will not receive the test, but will receive SRA (forming a third, "no-test" arm). Risk counseling is provided by clinic staff (not study staff external to the clinic). Fasting plasma glucose, insulin levels, body mass index (BMI), and waist circumference are measured at baseline and 12 months, as are patients' self-reported behavioral and emotional responses to diabetes risk information. Primary outcomes are changes in insulin resistance and BMI after 12 months; secondary outcomes include changes in diet patterns, physical activity, waist circumference, and perceived risk of developing diabetes. DISCUSSION: The utility, feasibility, and efficacy of providing patients with genetic risk information for common chronic diseases in primary care remain unknown. The study described here will help to establish whether providing type 2 diabetes genetic risk information in a primary care setting can help improve patients' clinical outcomes, risk perceptions, and/or their engagement in healthy behavior change. In addition, study design features such as the use of existing clinic personnel for risk counseling could inform the future development and implementation of care models for the use of individual genetic risk information in primary care. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00849563.
Aged, 80 and over
Attitude to Health
Diabetes Mellitus, Type 2
Genetic Predisposition to Disease
Outcome Assessment (Health Care)
Patient Education as Topic
Primary Health Care
Published Version (Please cite this version)10.1186/1472-6963-12-16
Publication InfoCho, Alex H; Killeya-Jones, Ley A; O'Daniel, Julianne M; Kawamoto, Kensaku; Gallagher, Patrick; Haga, Susanne; ... Ginsburg, Geoffrey S (2012). Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: study rationale, development and design. BMC Health Serv Res, 12. pp. 16. 10.1186/1472-6963-12-16. Retrieved from https://hdl.handle.net/10161/13545.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Assistant Professor of Medicine
Population health; telehealth; primary care; implementation science; applied genomics; health behavior; patient self-management; health policy.
Professor of Medicine
Dr. Geoffrey S. Ginsburg's research interests are in the development of novel paradigms for developing and translating genomic information into medical practice and the integration of personalized medicine into health care.
Associate Professor in Medicine
My research interests focus on issues affecting the translation of genomics to clinical practice. Specifically, I have a strong interest in education, with each of my research projects involving some component of professional, public or patient education, including development of educational materials about genomic research in general, pharmacogenetic testing, and communicating genetic test results, in addition to undergraduate teaching in genetics/genomics, ethics, and policy.A
Adjunct Associate Professor in the Department of Medicine
Leadership Positions: Chief of Clinical Services, Division of General Internal Medicine Medical Director, Duke Health Center at Pickett Road Professional Committee Assignments: Pharmacy and Therapeutics Committee, Duke Hospital Primary Care Management Committee, Private Diagnostics Clinics Interdisciplinary Medical Decision Making Initiative, Duke School of Medicine and Duke Fuqua School of Business Physician Advisory Group, Duke Pr
Associate Research Professor in the Social Science Research Institute
This author no longer has a Scholars@Duke profile, so the information shown here reflects their Duke status at the time this item was deposited.
Assistant Consulting Professor in the Department of Family Medicine and Community Health
Outcomes Research Chronic Disease Managment Based Research: Congestive Heart Failure, Diabetes, Cardiovascular Disease, Genomic Medicine Impact in Primary Care
Alphabetical list of authors with Scholars@Duke profiles.
Showing items related by title, author, creator, and subject.
Stoertz, Aaron (2011)Health system strengthening is now recognized as a pressing global health priority. Motivated and productive health workers are a critical component of health systems. Low and middle-income countries need many more health ...
Loh, Hwee Min (2015)Contraceptive prevalence in Haiti remains low despite extensive foreign aid targeted at improving family planning.  Earlier studies have found that peer-informed learning have been successful in promoting sexual ...
Optimizing linkage and retention to hypertension care in rural Kenya (LARK hypertension study): study protocol for a randomized controlled trial. Vedanthan, Rajesh; Kamano, Jemima H; Naanyu, Violet; Delong, Allison K; Were, Martin C; Finkelstein, Eric A; Menya, Diana; ... (16 authors) (Trials, 2014-04-27)BACKGROUND: Hypertension is the leading global risk factor for mortality. Hypertension treatment and control rates are low worldwide, and delays in seeking care are associated with increased mortality. Thus, a critical component ...